As of June 21, 2025, Nouveau Life Pharmaceuticals Inc (NOUV) reports a Gross Margin of 7775.20%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Comparing Nouveau Life Pharmaceuticals Inc's Gross Margin to Peers
To better understand Nouveau Life Pharmaceuticals Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Nouveau Life Pharmaceuticals Inc (NOUV) | 7775.20% |
| NanoSphere Health Sciences Inc (NSHS.CN) | 7775.20% |
| Sunset Island Group Inc (SIGO) | 7775.20% |
| RespireRx Pharmaceuticals Inc (RSPI) | 7775.20% |
| Rise Life Science Corp (RLSC.CN) | 6291.29% |
| Provention Bio Inc (PRVB) | 96.03% |
Compared to its competitors, Nouveau Life Pharmaceuticals Inc's Gross Margin is higher than all peers, indicating superior product pricing power or cost efficiency in production.